DRUG · Mapped RxNorm record
Metformin Extended Release Oral Tablet
Normalized identity: metformin Extended Release Oral TabletView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer
NCT04741204
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedMetformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer
Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
Woman'slead sponsor
Our Lady of the Lake Hospitalcollaborator
American Cancer Society, Inc.collaborator
Pfizercollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04741204 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.